Algert Global’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.82M Sell
625,797
-253,201
-29% -$3.16M 0.1% 344
2025
Q4
$11.4M Buy
878,998
+196,140
+29% +$2.52M 0.18% 155
2025
Q3
$8.82M Buy
682,858
+538,235
+372% +$7.19M 0.15% 223
2025
Q2
$2.57M Buy
144,623
+46,872
+48% +$817K 0.05% 554
2025
Q1
$1.74M Buy
97,751
+28,490
+41% +$647K 0.04% 637
2024
Q4
$2.06M Buy
+69,261
New +$1.47M 0.05% 598
2024
Q3
Sell
-13,800
Closed -$236K 1453
2024
Q2
$236K Sell
13,800
-17,203
-55% -$303K 0.01% 1220
2024
Q1
$485K Buy
+31,003
New +$456K 0.02% 767
2023
Q1
Sell
-5,371
Closed -$394K 1255
2022
Q4
$394K Sell
5,371
-1,336
-20% -$101K 0.02% 872
2022
Q3
$510K Buy
+6,707
New +$523K 0.03% 801
2021
Q1
Sell
-7,841
Closed -$1.36M 500
2020
Q4
$1.36M Sell
7,841
-11,099
-59% -$1.52M 0.39% 89
2020
Q3
$2.11M Buy
+18,940
New +$1.51M 0.67% 34

Other funds holding NVCR